ENDOMETRIAL CARCINOMA (EC)
Clinical trials for ENDOMETRIAL CARCINOMA (EC) explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA (EC) trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA (EC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to boost immune system against two cancers before surgery
Disease control OngoingThis study tests a drug called TPST-1495 in 10 people with endometrial or colorectal cancer who are scheduled for surgery. The drug targets specific receptors to help the immune system fight cancer. Researchers will check blood and tumor samples before and after treatment to see …
Matched conditions: ENDOMETRIAL CARCINOMA (EC)
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New pill targets Cancer's 'Engine' in first human trial
Disease control OngoingThis is a first-in-human study to test the safety and find the right dose of an experimental pill called ATV-1601. It is for adults with advanced solid tumors, including certain breast, gynecologic, and prostate cancers, that have a specific genetic change called an AKT1 E17K mut…
Matched conditions: ENDOMETRIAL CARCINOMA (EC)
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Apr 13, 2026 20:17 UTC